Interstitial lung disease related to rheumatoid arthritis: Evolution after treatment

Reumatologia Clinica

Volumn 8, Issue 2, 2012, Pages 68-71

  Rojas Serrano, Jorge ^a   González Velásquez, Edilzar ^a   Mejía, Mayra ^a   Sánchez Rodríguez, Alain ^b   Carrillo, Guillermo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Interstitial lung disease; Methotrexate; Pulmonary function tests; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CARBON MONOXIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MALE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPIROMETRY;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LUNG DISEASES, INTERSTITIAL; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84858440748     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.12.008     Document Type: Article

References (16)

1. Isenberg D.A., Maddison P.J., Woo P.G.D., Breedveld Ferdinand C. Rheumatoid arthritis, the clinical picture. Oxford textbook of rheumatology 2010, [Chapter 6]. 3rd ed.
2. Koduri G., Norton S., Young A., Cox N., Davies P., Devlin J., et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 2010, 49:1483-1489.
3. Nakajima A., Inoue E., Tanaka E., Singh G., Sato E., Hoshi D., et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 2010, 39:360-367.
4. Bongartz T., Nannini C., Medina-Velasquez Y.F., Achenbach S.J., Crowson C.S., Ryu J.H., et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010, 62:1583-1591.
5. Demedts M., Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 2002, 19:794-796.
6. Lee H.K., Kim D.S., Yoo B., Seo J.B., Rho J.Y., Colby T.V., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127:2019-2027.
7. Kim E.J., Collard H.R., King T.E. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009, 136:1397-1405.
8. Kim E.J., Elicker B.M., Maldonado F., et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010, 35:1322-1328.
9. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
10. Kazerooni E.A., Martinez F.J., Flint A., et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997, 169:977-983.
11. Krause D., Schleusser B., Herborn G., Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000, 43:14-21.
12. Smolen J.S., Landewe R., Breedveld F.C., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975.
13. Saravanan V., Kelly C. Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology 2006, 45:787-789.
14. Park I.N., Kim D.S., et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007, 132:214-220.
15. Akira M., Hamada H., Sakatani M., Kobayashi C., Nishioka M., Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997, 168:79-83.
16. Wolfe F., Caplan L., Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol 2007, 36:172-178.